INJECTION SITE HYPERTROPHY

This adverse event was reported 326 times

These drugs are most commonly taken by patients reporting INJECTION SITE HYPERTROPHY:

# Drug Count
0 ASFOTASE ALFA 51
1 PEGVISOMANT 28
2 INTERFERON BETA-1A 27
3 INSULIN GLARGINE 25
4 ETANERCEPT 24
5 METFORMIN 20
6 INSULIN GLARGINE-YFGN 17
7 METFORMIN ER 500 MG 17
8 METFORMIN ER 750 MG 17
9 ADALIMUMAB 15
See all common drugs associated with INJECTION SITE HYPERTROPHY

INJECTION SITE HYPERTROPHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PEGVISOMANT 28 0.0068
1 SOMAPACITAN-BECO 1 0.0055
2 ASFOTASE ALFA 51 0.0049
3 SETMELANOTIDE 1 0.0035
4 EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT) 1 0.0021
5 DEOXYCHOLIC ACID 4 0.0017
6 MECASERMIN 1 0.0012
7 RILONACEPT 1 0.0009
8 SOMATROGON-GHLA 1 0.0008
9 INSULIN GLARGINE-YFGN 17 0.0008
See all drugs enriched for association with INJECTION SITE HYPERTROPHY